Aerie Pharmaceuticals reported $-30566000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alimera Sciences ALIM:US $ -3.1M 2.86M
Amarin AMRN:US $ -64.8M 36.45M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cara Therapeutics CARA:US $ -4206000 23.54M
Coherus Biosciences CHRS:US $ -50.15M 45.93M
Insmed INSM:US $ -95144000 908K
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 4129M 217M
Ophthotech OPHT:US $ -49.26M 14.73M
Revance Therapeutics RVNC:US $ -61.44M 2.91M
Supernus Pharmaceuticals SUPN:US $ 11.32M 3.4M